FM, F., D, P., AT, C., MS, S., VM, M., GD, J., . . . NJ, M. (2013). HDAC inhibitor confers radiosensitivity to prostate stem-like cells. British journal of cancer, 109(12), 3023. https://doi.org/10.1038/bjc.2013.691
Chicago Style (17th ed.) CitationFM, Frame, Pellacani D, Collins AT, Simms MS, Mann VM, Jones GD, Meuth M, Bristow RG, and Maitland NJ. "HDAC Inhibitor Confers Radiosensitivity to Prostate Stem-like Cells." British Journal of Cancer 109, no. 12 (2013): 3023. https://doi.org/10.1038/bjc.2013.691.
MLA (9th ed.) CitationFM, Frame, et al. "HDAC Inhibitor Confers Radiosensitivity to Prostate Stem-like Cells." British Journal of Cancer, vol. 109, no. 12, 2013, p. 3023, https://doi.org/10.1038/bjc.2013.691.
Warning: These citations may not always be 100% accurate.